Allison J. Li

473 total citations
7 papers, 239 citations indexed

About

Allison J. Li is a scholar working on Hematology, Molecular Biology and Epidemiology. According to data from OpenAlex, Allison J. Li has authored 7 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 2 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Allison J. Li's work include Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Allison J. Li is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Allison J. Li collaborates with scholars based in United States and Czechia. Allison J. Li's co-authors include Laura M. Calvi, Benjamin J. Frisch, Michael W. Becker, Jane L. Liesveld, Sophia Balderman, Corey M. Hoffman, Mary Georger, Mark W. LaMere, Andrew G. Evans and Kathleen E. McGrath and has published in prestigious journals such as Nature Communications, Blood and The FASEB Journal.

In The Last Decade

Allison J. Li

7 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allison J. Li United States 6 124 109 49 48 35 7 239
Amie K. Waller United Kingdom 6 182 1.5× 85 0.8× 57 1.2× 106 2.2× 15 0.4× 7 310
Magnus Tobiasson Sweden 9 269 2.2× 127 1.2× 140 2.9× 36 0.8× 26 0.7× 23 336
Orna Steinberg‐Shemer Israel 8 85 0.7× 113 1.0× 65 1.3× 28 0.6× 9 0.3× 30 237
Victoria Empson Austria 7 86 0.7× 58 0.5× 52 1.1× 106 2.2× 17 0.5× 12 241
Douglas J. Scothorn United States 5 86 0.7× 67 0.6× 82 1.7× 79 1.6× 21 0.6× 6 242
Vilma Dembitz Croatia 10 93 0.8× 193 1.8× 47 1.0× 17 0.4× 46 1.3× 21 285
K. Ozeki Japan 6 196 1.6× 126 1.2× 70 1.4× 22 0.5× 7 0.2× 9 298
Verena Wais Germany 8 55 0.4× 46 0.4× 51 1.0× 25 0.5× 23 0.7× 21 193
Heather Allewelt United States 7 38 0.3× 66 0.6× 32 0.7× 30 0.6× 40 1.1× 12 185
CL Miller United States 3 107 0.9× 79 0.7× 41 0.8× 69 1.4× 137 3.9× 4 343

Countries citing papers authored by Allison J. Li

Since Specialization
Citations

This map shows the geographic impact of Allison J. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison J. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison J. Li more than expected).

Fields of papers citing papers by Allison J. Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison J. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison J. Li. The network helps show where Allison J. Li may publish in the future.

Co-authorship network of co-authors of Allison J. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Allison J. Li. A scholar is included among the top collaborators of Allison J. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison J. Li. Allison J. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Li, Allison J. & Jae H. Park. (2025). Interpreting the clinical outcomes to date for AML-directed CAR T cell therapies. Current Opinion in Oncology. 37(6). 658–668. 1 indexed citations
2.
Li, Allison J., Charles O. Smith, Jane Zhang, et al.. (2023). Efferocytosis by bone marrow mesenchymal stromal cells disrupts osteoblastic differentiation via mitochondrial remodeling. Cell Death and Disease. 14(7). 428–428. 18 indexed citations
3.
Calvi, Laura M., Allison J. Li, & Michael W. Becker. (2019). What is the role of the microenvironment in MDS?. Best Practice & Research Clinical Haematology. 32(4). 101113–101113. 7 indexed citations
4.
Ayoub, Edward, Michael P. Wilson, Kathleen E. McGrath, et al.. (2018). EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription. Nature Communications. 9(1). 4239–4239. 37 indexed citations
5.
Li, Allison J. & Laura M. Calvi. (2017). The microenvironment in myelodysplastic syndromes: Niche-mediated disease initiation and progression. Experimental Hematology. 55. 3–18. 44 indexed citations
6.
Balderman, Sophia, Allison J. Li, Corey M. Hoffman, et al.. (2015). Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome. Blood. 127(5). 616–625. 67 indexed citations
7.
Bibee, Kristin, James Kain Ching, Jon N. Marsh, et al.. (2014). Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function. The FASEB Journal. 28(5). 2047–2061. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026